Our Business_Fosun Pharma

      竞技宝·(JJB)官网 - 华语电竞行业引领者

      Integrated Development

      As a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China, Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

      • Pharmaceutical Manufacturing

      • Vaccines

      • Medical Devices

      • Medical Diagnosis

      • Healthcare Services

      • Pharmaceutical Distribution and Retail

      Steady Financial Growth

      • FY2024 Revenue

        410,67 Million

      • FY2024 Net Profit Attributable to Shareholders

        2,770 Million

        YOY16.08%

      • FY2024 Net Cash Flow from operating activities

        4,477 Million

        YOY31.13%

      * Unit: RMB million
      As of December 31, 2024

      Open R&D Ecology

      • Independent R&D
      • Co-development
      • Industrial investment
      • License-in

      • Pharmaceutical Manufacturing

        Pharmaceutical Manufacturing

        Pharmaceutical manufacturing is the core business of Fosun Pharma, including three major segments: innovator drugs, mature products and manufacturing, and vaccines.

        • Oncology and Immunomodulation
        • Metabolism and Digestive System
        • Central Nervous System
        • Anti-infection
        • Cardiovascular System
        • APIs and Intermediates

      • Vaccines

        Vaccines

        The Vaccine Division has established an independent R&D system centered on two major technical platforms of bacterial vaccines and viral vaccines, and further broadened the vaccine pipeline through cooperative development to enhance the vaccine industrialization capability.

        • COVID-19
        • mRNA COVID-19 Vaccine

      • Medical Devices

        Medical Devices

        As one of the important segments of Fosun Pharma, Fosun Med-tech integrated several subsidiaries at home and abroad and has initially formed three major business divisions with medical aesthetics, Respiratory Health and professional medical care

        • Medical Aesthetics
        • Respiratory Health
        • Professional Medical Technology and Devices

      • Medical Diagnosis

        Medical Diagnosis

        Founded in 1989, Fosun Diagnosis adheres to the mission of "Integrating innovative diagnostic technologies and protecting global life and health", promotes the development of innovative technologies and products, focuses on in vitro diagnosis industry, and is committed to becoming the world's leading technology innovator of integrated medical diagnosis solutions.

        • Biochemical Diagnosis
        • Immune Diagnosis
        • Molecular Diagnosis
        • Microbiological Diagnosis
        • Chronic-care Management
        • Pathological Diagnosis

      • Healthcare Services

        Healthcare Services

        Taking ‘‘making families healthier and life better’’ as the mission, Fosun Health gives full play to its core industrial advantages in the fields of medical care, medicine, insurance, health consumption, digital and intelligent technology, etc. Fosun Health is committed to building a medical-grade, full-scenario and one-stop health ecosystem, and becoming a ‘‘leader of active family health management’’.

        • Special Disease Healthcare
        • Consumer & Healthcare Services
        • Pharmaceutical
        • E-Commerce Insurance
        • Healthcare Services

      • Pharmaceutical Distribution and Retail

        Pharmaceutical Distribution and Retail

        In 2003, Fosun Pharma and China National Pharmaceutical Group Corporation jointly established Sinopharm Group.
        Sinopharm Group is a distributor of pharmaceuticals and healthcare products and a leading supply chain service provider in China.